Stoke Therapeutics, Inc. STOK Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$169.77M-438% | -$6.89M+92.3% | $40.57M+138% | $52.48M+151% | $50.27M+146% | ||
| $1.73M-17.2% | $1.77M-18.7% | $1.89M-16.9% | $1.99M-16.1% | $2.09M-14.1% | ||
| $34.24M+18.8% | $32.24M+17.4% | $29.53M+11.9% | $28.98M+13.9% | $28.81M+16.3% | ||
| —— | —— | —— | —— | $69.54M+183% | ||
| $871K+154% | $670K+230% | $480K+23.1% | $451K-32.7% | $343K-76.6% | ||
| -$158.84M-51.8% | -$195.91M-80.9% | -$134.85M-44.2% | -$164.85M-237% | -$104.65M-267% | ||
| $180.34M+37.9% | $97.39M-25.7% | $5.62M-95.9% | $10.66M-91.8% | $130.75M+1,252% | ||
| -$117.06M-221% | -$44.66M+29.4% | -$66.47M-66.3% | -$91.78M-2,723% | $96.46M+1,097% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Stoke Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Stoke Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.